Colgate-Palmolive Eyes Strong Levels of Brand Investment Following Q1 Performance, Raises Annual Revenue Growth Outlook
Portfolio Pulse from Shivani Kumaresan
Colgate-Palmolive (NYSE:CL) reported a 6.2% increase in Q1 FY24 sales to $5.065 billion, surpassing analyst expectations. Organic sales rose by 9.8%, with Oral, Personal, and Home Care net sales up 6.8% to $3.96 billion. Non-GAAP EPS of $0.86 exceeded estimates of $0.81. The company saw gross profit of $3.03 billion and an operating margin expansion to 20.7%. Colgate-Palmolive raised its FY24 net sales growth outlook to 2%-5% and organic sales growth to 5%-7%, maintaining expectations for gross profit margin expansion and mid to high-single-digit EPS growth. Shares increased by 0.85% to $90.05 in premarket trading.

April 26, 2024 | 12:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Colgate-Palmolive reported a strong Q1 FY24 performance with sales and EPS exceeding expectations, leading to an upward revision in FY24 sales and organic growth outlook. Shares rose 0.85% in premarket trading.
The positive earnings report and upward revision in sales and organic growth outlook for FY24 indicate strong financial health and operational efficiency, likely leading to increased investor confidence and potential stock price appreciation in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100